Cargando…

Resveratrol enhances polyubiquitination-mediated ARV7 degradation in prostate cancer cells

Although androgen deprivation therapy (ADT) serves as the primary treatment option for localized or metastatic prostate cancer, most cases eventually develop into castration-resistant prostate cancer (CRPC). However, androgen receptor (AR) continues to be functional in CRPC through various mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilson, Sarah, Cavero, Lucia, Tong, Dali, Liu, Qiuli, Geary, Kyla, Talamonti, Nicholas, Xu, Jing, Fu, Junjiang, Jiang, Jun, Zhang, Dianzheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589613/ https://www.ncbi.nlm.nih.gov/pubmed/28903374 http://dx.doi.org/10.18632/oncotarget.18003

Ejemplares similares

The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment
por: Silk, Natalie, et al.
Publicado: (2021)

Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT
por: Liu, Qiuli, et al.
Publicado: (2017)

Case Report: Co-Existence of BRCA2 and PALB2 Germline Mutations in Familial Prostate Cancer With Solitary Lung Metastasis
por: Tang, Tang, et al.
Publicado: (2020)

Women and ARV-based prevention: opportunities and challenges
por: Geary, Cynthia W, et al.
Publicado: (2014)

Women and ARV-based HIV prevention – challenges and opportunities
por: Geary, Cynthia W, et al.
Publicado: (2014)

A novel inhibitor of ARfl and ARv7 induces protein degradation to overcome enzalutamide resistance in advanced prostate cancer
por: Li, Yan, et al.
Publicado: (2022)

Emerging Therapeutic Strategies for COVID-19 patients
por: Zhu, Shudong, et al.
Publicado: (2020)

Preclinical studies using cisplatin/carboplatin to restore the Enzalutamide sensitivity via degrading the androgen receptor splicing variant 7 (ARv7) to further suppress Enzalutamide resistant prostate cancer
por: Chou, Fu-Ju, et al.
Publicado: (2020)

New ARV drugs
por: Gulick, Roy
Publicado: (2014)

RNF8 up-regulates AR/ARV7 action to contribute to advanced prostate cancer progression
por: Zhou, Tingting, et al.
Publicado: (2022)

Development of long-acting ARV’s
por: Boffito, Marta
Publicado: (2014)

Polyubiquitin chain assembly and organization determine the dynamics of protein activation and degradation
por: Nguyen, Lan K., et al.
Publicado: (2014)

ARV-825-induced BRD4 protein degradation as a therapy for thyroid carcinoma
por: He, Ling, et al.
Publicado: (2020)

Androgen receptor splicing variant 7 (ARV7) inhibits docetaxel sensitivity by inactivating the spindle assembly checkpoint
por: Yu, Bingbing, et al.
Publicado: (2021)

The dynamics of linear polyubiquitin
por: Jussupow, Alexander, et al.
Publicado: (2020)

ARV regimen choice and co-morbidities
por: Peters, Barry
Publicado: (2014)

A Novel, Circulating Tumor Cell Enrichment Method Reduces ARv7 False Positivity in Patients with Castration-Resistant Prostate Cancer
por: Nakasato, Takehiko, et al.
Publicado: (2020)

Non-Covalent Interaction between Polyubiquitin and GTP Cyclohydrolase 1 Dictates Its Degradation
por: Zhao, Yu, et al.
Publicado: (2012)

Dendritic Cell IL-1α and IL-1β Are Polyubiquitinated and Degraded by the Proteasome
por: Ainscough, Joseph S., et al.
Publicado: (2014)

Mechanism of selective recognition of Lys48-linked polyubiquitin by macrocyclic peptide inhibitors of proteasomal degradation
por: Lemma, Betsegaw, et al.
Publicado: (2023)

Preclinical Study Using ABT263 to Increase Enzalutamide Sensitivity to Suppress Prostate Cancer Progression Via Targeting BCL2/ROS/USP26 Axis Through Altering ARv7 Protein Degradation
por: Xu, Hua, et al.
Publicado: (2020)

Targeting the radiation-induced ARv7-mediated circNHS/miR-512-5p/XRCC5 signaling with Quercetin increases prostate cancer radiosensitivity
por: Chen, Dong, et al.
Publicado: (2022)

Patent Pools for ARVs: Industry Perspectives from ASPEN
por: Nicolaou, Stavros
Publicado: (2010)

Environmental Risk Characterization of an Antiretroviral (ARV) Lamivudine in Ecosystems
por: Omotola, Elizabeth Oyinkansola, et al.
Publicado: (2021)

The Dark Side of EGFP: Defective Polyubiquitination
por: Baens, Mathijs, et al.
Publicado: (2006)

Recent advances in polyubiquitin chain recognition
por: Wu, Hao, et al.
Publicado: (2010)

Regulation of PCNA polyubiquitination in human cells
por: Brun, Jan, et al.
Publicado: (2010)

Detection of Androgen Receptor Variant 7 (ARV7) mRNA Levels in EpCAM-Enriched CTC Fractions for Monitoring Response to Androgen Targeting Therapies in Prostate Cancer
por: Hille, Claudia, et al.
Publicado: (2019)

Recombinant Newcastle Disease Virus (NDV) Expressing Sigma C Protein of Avian Reovirus (ARV) Protects against Both ARV and NDV in Chickens
por: Saikia, Deep Prakash, et al.
Publicado: (2019)

A novel BRCA2 mutation in prostate cancer sensitive to combined radiotherapy and androgen deprivation therapy
por: Liu, Qiuli, et al.
Publicado: (2018)

Phosphorylation of Kif26b Promotes Its Polyubiquitination and Subsequent Proteasomal Degradation during Kidney Development
por: Terabayashi, Takeshi, et al.
Publicado: (2012)

Smurf1 and Smurf2 mediated polyubiquitination and degradation of RNF220 suppresses Shh-group medulloblastoma
por: Li, Yuwei, et al.
Publicado: (2023)

Repressive Effects of Resveratrol on Androgen Receptor Transcriptional Activity
por: Shi, Wen-feng, et al.
Publicado: (2009)

Different RET gene mutation-induced multiple endocrine neoplasia type 2A in 3 Chinese families
por: Liu, Qiuli, et al.
Publicado: (2017)

Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial)
por: Bratic Hench, Ivana, et al.
Publicado: (2019)

Resveratrol in prostate diseases
por: Salagierski, Maciej
Publicado: (2013)

Germline Mutations in Patients With Early-Onset Prostate Cancer
por: Tang, Tang, et al.
Publicado: (2022)

BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes
por: Wu, Shuiyan, et al.
Publicado: (2021)

ARV formulated microbicides big promise; as world waits vaccine
por: Ondari, Ronald Orutwa, et al.
Publicado: (2009)

The clinic-biological progress of patients on ARV under D.O.T
por: Lyli, O, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_oa75tcv6vtt2nktu0lbo0uccgr